Amoy Diagnostics Co Ltd

Chart & Performance

D1W1MN

P/E

18.81

P/S

5.67

EPS

0.93

Div Yield, %

1.77%

Shrs. gr., 5y

-0.08%

Rev. gr., 5y

5.48%

Revenues

1.20b

+8.00%

Net income

361m

+41.74%

CFO

365m

+6.72%

Dividend

Jun 03, 20250.3 CNY/sh

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Profile

Amoy Diagnostics Co., Ltd. is a diagnostics company focused on molecular diagnostic solutions for precision oncology. Operating both within China and across international markets, the firm provides a range of sophisticated assays, including Next-Generation Sequencing (NGS), real-time PCR, Fluorescence In Situ Hybridization (FISH), and various extraction methods. Established in 2008, Amoy Diagnostics has its base in Xiamen, China.

URL

https://www.amoydx.com/

IPO date

Aug 02, 2017

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title CNY in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title CNY in thousands, except ratios and share amounts	2025‑12	2024‑12	2023‑12	2023‑00	2022‑12	2022‑00	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT